Clinical Trial Update: Improve Checkpoint-blockade Response in Advanced Urothelial Cancer [Phase 1, Phase 2]

View source ↗

Summary

This entry reports the completion of a Phase 1/2 clinical trial investigating strategies to improve response to checkpoint inhibitors in advanced urothelial car…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Urothelial Carcinoma

Snippet

Sponsor: The Netherlands Cancer Institute | Conditions: Urothelial Carcinoma | Phase 1, Phase 2 | Status: COMPLETED